Bioequivalence Study of 3 New Formulations of Premarin/MPA Compared With

See also
Status	Clinical Trial	Phase
Completed	`NCT05448079` - The Effect of Sexual Counseling Given According to the PLISSIT Model on FSFI, MAS and SQOL-F of Postmenopausal Women	N/A
Completed	`NCT00745173` - Study Evaluating Premarin and Bazedoxifene Potential Interaction	Phase 1
Completed	`NCT00913926` - Effects of Wellnara on Climacteric Symptoms	N/A
Completed	`NCT00550433` - Study Evaluating Bazedoxifene/CE in Postmenopausal Women	Phase 1
Completed	`NCT00515593` - PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)	N/A
Completed	`NCT00381251` - Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation.	Phase 1
Completed	`NCT00484107` - Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women	Phase 4
Completed	`NCT00185328` - Efficacy and Tolerability of Angeliq in Thai Women	Phase 4
Completed	`NCT00023543` - Reduction of Triglycerides in Women on Hormone Replacement Therapy	Phase 2
Completed	`NCT00152282` - A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women	Phase 2
Completed	`NCT00006407` - Sex Steroid Hormones and Risk of CHD in Women	N/A
Completed	`NCT00010712` - Effects of Black Cohosh on Menopausal Hot Flashes	Phase 2
Completed	`NCT00006539` - Thrombotic, Inflammatory & Gene Markers of CVD in Women	N/A
Completed	`NCT00005515` - Mutations, Hormone Therapy (HRT) and Venous Thromboembolism	N/A
Completed	`NCT00001752` - Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women	Phase 2
Completed	`NCT00000481` - Women's Health Trial: Feasibility Study in Minority Populations	Phase 3
Completed	`NCT00000466` - Postmenopausal Estrogen/Progestin Interventions (PEPI)	Phase 3
Completed	`NCT00543634` - Study Comparing Premarin®/MPA, PREMPRO® and Provera® in Healthy Postmenopausal Women	Phase 1
Completed	`NCT06115577` - Endometrial Tissues and Mononuclear Cells Receptivity in Pathogenesis of Endometrial Proliferative Processes
Completed	`NCT01556737` - Effect of Two Different Isoflavone Supplement Preparations on Gene-expression in Postmenopausal Women	N/A

NCT number	NCT00472927
Study type	Interventional
Source	Wyeth is now a wholly owned subsidiary of Pfizer
Contact
Status	Completed
Phase	Phase 1
Start date	May 2007
Completion date	August 2007

Bioequivalence Study of 3 New Formulations of Premarin/MPA Compared With Premarin/MPA (Prempro)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms